Contraceptives Flashcards

(56 cards)

1
Q

Primary MOA of hormonal contraceptives

A

inhibition of ovulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hormonal components of contraceptive

A

estrogen (synthetic)
– ethinyl estradiol (EE)
progestins (synthetic progesterone analogs) –
levonorgestrel (LNG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

common oral OCPs

A
monophonic products
biphasic products
triphasic products
quadriphonic products
Progestin only (mini pill)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

non contraceptive benefits of HC’s

A

increased hemoglobin (some OC’s contain Fe2+)
reduced risk of fetal neural tube defects (some contain folate)
decreased vasomotor symptoms (‘hot flashes”) in postmenopausal women
increased BMD in perimenopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adverse effects of OCPs

A

venous thromboembolism (VTE)
CA
CV effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

greatest risk factors for VTE with OCPs

A

obesity, smokers, HTN, diabetics, recent post-op & previous DVT.

Use progestin only Has in these patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

least risk for VTE is with progestin:

A

levonorgestrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CA with OCPs is mostly associated w/ ____

A

unopposed estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

lower EE increases risk of ___

A

failure (pregnancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HC users with HTN have a higher risk of ___ or ___

A

MI; stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

E2 HCs are not recommended for ____, ___ or ___

A

smokers >35, women w/ HTN, migraines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

less serious S/E of HC can be minimized/avoided by adjusting ___

A

E2 and or progestin content

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

transdermal patch that is no longer available

A

Evra (ortho)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

transdermal patch. delivers __/__

A

EE/norelgestromin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

administration of transdermal patch

A

apply 1 patch weekly x 3 weeks, then 1 week with no patch.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

transdermal patch is less effective in women ___

A

> 90kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

vaginal ring: __/__

A

EE/etonogestrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

administration of vaginal ring

A

left in place x 3 wks

then 1 wk ring free interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

vaginal ring return to fertility after removal

A

rapid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

with vaginal ring, users report less ___, ___,___ and ___

A

nausea
acne
irritability
depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Injectable hormonal contraception dosage

A
Depo provera (DMPA) -- IM q3mo
depo-subQ provera: SC q3mo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

injectable hormonal contraception have improved. ___

A

adherence over OC’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

side effects of injectables

A

decreased BMD

24
Q

labeling recommends to discontinue injectables after ___

A

2 yrs o f u se

25
__ may be delayed after use of injectable hormonal contraception
fertility
26
DMPA:
dopo medroxyprogeserone acetate
27
long acting reversible contraception
subdermal implant | intrauterine device
28
IUD:
``` non hormonal (copper) hormonal ```
29
subdermal implant duration of use
3 year duration of use
30
subdermal implant contains ___ for x ray visualization
barium
31
Subdermal implant is not affected by ___
BMI
32
subdermal implant is safe immediately ___ or ___
postpartum or abortion
33
copper IUD duration of use
10 years
34
most effective form of emergency contraception
copper IUD
35
main s/e of copper IUD
increased menstrual bleeding
36
hormonal IUDs duration of use
3-5 years
37
unlike Cu-IUD, hormonal IUDs tend to decrease ___
menstrual bleeding
38
IUD can be unsuccessful in up to ___%
18%
39
risk o expulsion of IUD immediacy post placental delivery
3-27%
40
risk of expulsion of IUD 10min-48h post placenta delivery
11-27%
41
risk of expulsion of IUD 4-8 wks post partum
0-6%
42
IUD has risk of ___
uterine perforation
43
emergency contraception pills:
``` progestin ECPs (available OTC, no age restriction) Antiprogestin ECPs (rx only) ```
44
progestin ECP uses
levonorgestrel
45
atiprogestin ECP uses
ulipristal acetate
46
antiprogestin is more effective than ___
progestin ECP
47
antiprogestin may be taken up. to ____ post intercourse
5 days
48
___ is prudent in EPC use
prompt use
49
copper IUD is the more effective than ___
ECPs.
50
copper IUD may be inserted up to ___ post intercourse
10 days
51
abortifacients
mifepristone RU-486
52
mifepristone is given with other ___
prostaglandins (PO misoprostol)
53
success rates with aborticfacents
>90% with pregnancies <49 days
54
EE is metabolized mainly by __
CYP3A4
55
3A4 inducers increase ____
Has metabolism, increasing risk of pregnancy
56
3a4 inducers:
anticonvulsants antiretrovirals (HIV meds) St John's wort